SCHEMBL7017182

SCHEMBL7017182

COC(=O)c1ccc(C(=O)N2CCCOc3ccccc32)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52
PDE4D Q08499 1/20 0.52
MAPT P10636 3/20 0.48
POLB P06746 3/20 0.48
LMNA P02545 2/20 0.47
RXFP1 Q9HBX9 1/20 0.46
AVPR2 P30518 1/20 0.46
NR3C2 P08235 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PDCD1 Q15116 2/20 0.44
CD274 Q9NZQ7 2/20 0.44
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
NOTUM Q6P988 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012627 0.91 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL7024013 0.81 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL7019627 0.81 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL7020943 0.79 AVPR1A (0.55) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL7020707 0.79 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL7019784 0.79 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL2933189 0.78 AVPR2 (0.52) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL7020818 0.78 MAPT (0.43) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL5012624 0.77 POLB (0.70) MAPTPOLBLMNARXFP1NR3C2
SCHEMBL5010850 0.77 POLB (0.58) MAPTPOLBLMNARXFP1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051415-B1 BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-09-24 EP disclosed
US-6495542-B1 SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-17 US disclosed